Table 1.
Variable | Samples (Patients) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Unadjusted Model, n = 122 (n = 61) | Adjusted for Sex and Age, n = 122 (n = 61) | Adjusted for Sex, Age, and BMI, n = 84 (n = 42) | Adjusted for Sex, Age, BMI, and T Stage, n = 84 (n = 42) | Adjusted for Sex, Age, BMI, and Dukes’ Stage, n = 84 (n = 42) | ||||||
Change, % (95% CI) | P Value | Change, % (95% CI) | P Value | Change, % (95% CI) | P Value | Change, % (95% CI) | P Value | Change, % (95% CI) | P Value | |
Cancera | 24.8 (12.5 to 37.0) | < 0.001 | 24.8 (12.5 to 37.0) | < 0.001 | 24.6 (10.3 to 38.8) | 0.001 | 24.6 (10.3 to 38.8) | 0.001 | 24.6 (10.3 to 38.8) | 0.001 |
Male sexb | −17.6 (−36.1 to 0.8) | 0.061 | −21.8 (−37.2 to −6.3) | 0.006 | −20.6 (−36.4 to −4.7) | 0.011 | −23.3 (−39.9 to −6.7) | 0.006 | ||
Age | 0.5 (−0.3 to 1.4) | 0.266 | −0.2 (−0.9 to 0.4) | 0.502 | 0.0 (−0.8 to 0.9) | 0.961 | −0.3 (−1.0 to 4.7) | 0.466 | ||
BMI | −0.0 (−1.5 to 1.4) | 0.989 | −0.1 (−1.6 to 1.4) | 0.921 | −0.1 (−1.7 to 1.5) | 0.876 | ||||
T stagec | ||||||||||
2 | 26.6 (−26.2 to 79.3) | 0.323 | ||||||||
3 | 15.4 (−34.4 to 65.1) | 0.546 | ||||||||
4 | 22.0 (−29.2 to 73.2) | 0.400 | ||||||||
Dukes’ staged | ||||||||||
B | 2.1 (−23.6 to 27.8) | 0.872 | ||||||||
C | −2.0 (−26.1 to 22.0) | 0.867 | ||||||||
D | −32.2 (−87.0 to 22.5) | 0.249 |
The outcome used in modeling was log transformed STS activity, and estimates can be interpreted as approximate percentage changes.
Abbreviations: BMI, body mass index; CI, confidence interval.
Reference was normal.
Reference was female.
Reference was stage 1.
Reference was stage A.